Scientists at Oregon Health & Science University have developed a new molecule that could open the door to treating triple-negative breast cancer, one of the most aggressive and difficult-to-treat ...
How The Advanced Enzyme Technologies (NSEI:ADVENZYMES) Narrative Is Shifting Around A ₹370 Valuation
The fair value estimate for Advanced Enzyme Technologies has been kept steady at ₹370.0 per share, with no change in the headline price target despite refreshed model inputs. Bullish and bearish ...
Background Pharmacotherapy combinations have been shown to improve survival and reduce hospitalisations in adults with ...
Enzymes with specific functions are becoming increasingly important in industry, medicine and environmental protection. For example, they make it possible to synthesise chemicals in a more ...
Northwestern Medicine scientists led by Joseph Bass, MD, Ph.D., the Charles F. Kettering Professor of Endocrinology and ...
Researchers simulated nearly every molecule in a bacterial cell — and then watched the cell grow and reproduce.
News Medical on MSN
Scientists identify ANKIB1 as key regulator of innate immune signaling
Innate immune sensors – known as pattern recognition receptors (PRRs) – detect specific molecular components of bacterial or viral intruders. The PRRs forward the signals which results in the ...
News-Medical.Net on MSN
Single receptor PAR1 controls opposing responses in blood vessels
Researchers at the University of California San Diego have uncovered how a single protein triggers two opposite responses in blood vessels - one inflammatory and one protective. This protein, a ...
A new study led by Pierre Close's team (GIGA, Laboratory of Cancer Signaling, and WELRI Investigator) reveals how subtly ...
Read more about AI-powered peptide discovery could transform fight against drug-resistant superbugs on Devdiscourse ...
A research team led by scientists at the Butantan Institute in São Paulo, Brazil, has completed the most extensive genetic sequencing of a jararaca viper to date. The focus of the study was the genome ...
ArcticZymes Technologies ASA (OSE: "AZT") today hosts its Capital Markets Day 2026 in Stockholm, outlining how the Company is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results